Source: Annual Congress 2004 - Pathogenesis of OSA
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
J. M. Walker, R. J. Farney, K. M. Boyle, T. V. Cloward, K. C. Shilling (Salt Lake City, United States Of America). Does chronic opioid therapy alter the pattern of sleep apnea?. Eur Respir J 2004; 24: Suppl. 48, 2752

Member's Comments

No comment yet.

Related content which might interest you: Refractory sleep disordered breathing associated with chronic opioid therapy Source: Eur Respir J 2001; 18: Suppl. 33, 88s Year: 2001 Concomitant benzodiazepine and opioids decrease sleep apnoea risk in chronic pain patients Source: ERJ Open Res, 6 (3) 00093-2020; 10.1183/23120541.00093-2020 Year: 2020 Does CPAP therapy affect motor cortical excitability in patients with obstructive sleep apnea syndrome (OSAS)? Source: Annual Congress 2004 - CPAP therapy for OSA Year: 2004 The role of pharmacological treatments in sleep apnoea syndrome Source: Annual Congress 2004 - What's new in the treatment of sleep apnoea Year: 2004 Reported but not measured sleep latency predicts successful CPAP therapy in patients with obstructive sleep apnoea Source: Eur Respir J 2002; 20: Suppl. 38, 101s Year: 2002 Atypical patterns in portable monitoring for sleep apnoea: features of nocturnal epilepsy? Source: Eur Respir J 2013; 41: 368-375 Year: 2013 Night treatment with long acting ß2 agonists in mild COPD patients with sleep apnoea syndrome Source: Eur Respir J 2007; 30: Suppl. 51, 74s Year: 2007 Can leptin be used to treat obstructive sleep apnoea? Source: International Congress 2019 – New horizons for pharmacotherapy of sleep-disordered breathing: from bench to bedside Year: 2019 Daytime sleepiness in patients on intrathecal chronic opioid (IT) therapy is not related to sleep disordered breathing (SDB) Source: Annual Congress 2011 - Comorbid obstructive sleep apnoea (OSA) and OSA comorbidities Year: 2011 Insomnia related to sleep apnoea: effect of long-term auto-adjusting positive airway pressure treatment Source: Eur Respir J 2013; 41: 593-600 Year: 2013 Positional therapy for obstructive sleep apnea: do your patients use it at home? Source: Annual Congress 2009 - Assessment and therapeutical interventions in obstructive sleep apnoea Year: 2009 The influence of long-term CPAP therapy on metabolic variables in obstructive sleep apnea patients Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing Year: 2018 Clinical implications of residual sleep apnoea after chronic CPAP therapy Source: Breathe 2011; 7: 289-290 Year: 2011 The use of beta-blockers is not associated with increased daytime sleepiness in patients with obstructive sleep apnoea Source: International Congress 2019 – Beyond continuous positive airway pressure treatment Year: 2019 Role of common hypnotics on the phenotypic causes of obstructive sleep apnoea: paradoxical effects of zolpidem Source: Eur Respir J, 50 (6) 1701344; 10.1183/13993003.01344-2017 Year: 2017 Varenicline administration for smoking cessation may reduce apnea hypnea index in sleep apnea patients Source: Virtual Congress 2021 – Advances in therapeutic plans for sleep disordered breathing Year: 2021 Return of sleep apnoea and sleep fragmentation following CPAP withdrawal in patients with obstructive sleep apnoea Source: Eur Respir J, 53 (5) 1802351; 10.1183/13993003.02351-2018 Year: 2019 Compliance in sleep apnoea therapy: influence of home care support and pressure mode Source: Eur Respir J 2009; 33: 804-811 Year: 2009 The effect of concomitant COPD on obstructive sleep apnea syndrome severity and sleep structure Source: Annual Congress 2011 - Obstructive sleep apnoea as a comorbidity Year: 2011